GlobeNewswire

Synechron signs a Calypso implementation deal with SIX Group, the financial services provider and Swiss Stock Exchange infrastructure operator

Dela

PARIS, LONDON, AMSTERDAM, the Netherlands, NEW YORK and PUNE, India, July 19, 2017 (GLOBE NEWSWIRE) -- Synechron, a global financial services consulting and technology services provider, has signed a Calypso implementation agreement with the SIX Group Ltd., a financial services provider and Swiss Stock Exchange operator. Synechron was selected as systems integrator for the implementation of Calypso v15, the SFR (Securities Finance Renewal) Program, in collaboration with Calypso. The objective of the program is to update SIX's post-trade services where it acts as a contractual Triparty agent for its clients to enhance its Triparty collateral management services.

This innovative project is the first implementation where Calypso is being used to manage contractual Triparty agent activities. The project has been divided into two phases with the first to launch in January 2017. It is scheduled to last two years and will employ a total of forty staff from SIX, Calypso, and Synechron in 2017-2018.

"Synechron is a certified Calypso partner, which gives us access to considerable expertise and concrete Calypso implementation experience. Furthermore, Synechron already is working with Calypso in Switzerland, notably on collateral management implementation, which gives them highly relevant subject matter expertise," said Robert Bornträger, Division CEO of SIX IT who is responsible for the development and operation of SIX's IT Services since 2008.

Project scope and production support

The first team of twelve Synechron consultants was deployed on the SIX project during the first quarter of 2017. A portion of the team works on site while the rest is based at Synechron's European Delivery Centre in Serbia. Synechron's team of onsite and Serbia-based consultants have joined forces with staff from SIX and consultants from Calypso to work together to manage the project, integrate Calypso into SIX's systems, and build a testing and a production support team. Moreover, Synechron will play an important role in providing SIX staff with training covering the technical and functional aspects of Calypso. The project also includes a significant digital services offering which gives SIX clients access to the functionalities of the SFR project through their own infrastructures. 
                
A strategic and cultural fit

Synechron was chosen by SIX among four companies following a competitive call for vendors during 2016. "We are extremely pleased to participate in this ambitious and innovative SFR project together with SIX and with the support of our partner Calypso. This project consolidates all the knowledge we have built up over the past few years in terms of financial software integration including our expertise in collateral management," added Pascal Rellier, Managing Director, Synechron.

In addition to being a Calypso Alliance Partner, one of Synechron's key assets is the existence and strength of its Calypso Centre of Excellence with more than 50 Calypso experts in Europe able to provide in-house training with the Calypso Campus program. The Centre of Excellence was created in 2015. 

Furthermore, SIX has found a strategic partner in Synechron: "One of SIX's fundamental values is to foster working relationships with its suppliers that are based on trust. Synechron has shown its commitment to building a long-term partnership with us," added Roger Oehen, in charge of the SFR project at SIX.

About SIX

SIX operates the infrastructure underpinning the Swiss financial sector and offers a comprehensive range of services around the world in the fields of securities trading and settlement, financial information and payment transactions. The company is owned by its users (approximately 130 banks of various orientation and size). Its workforce of over 4,000 employees and presence in 25 countries throughout the world generated operating income of CHF 1.8 billion and a Group net profit of CHF 221.1 million in 2016.
www.six-group.com

About Synechron

Synechron is a global consulting and technology organization providing innovative solutions to the financial services industry through its three main business focus areas: digital, business consulting, and technology. Based in New York, the company has 18 offices around the globe, with over 8,000 employees producing more than $500M in annual revenue. If you would like to find out more about the company, please visit the website or our LinkedIn community.

For any further information please contact: 

SIX Group Contact 
Jürg Schneider
Deputy Head Media Relations
pressoffice@six-group.com
Tel.:+41 58 399 2129

Synechron USA
Diana Kearns-Manolatos
Senior Director, Marketing 
Diana.kearns@synechron.com
m: +1 347-721-8223

Synechron Europe 
Karin Bendayan
Marketing Director
karin.bendayan@synechron.com
Tel: + 33 1 42 65 92 54




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Synechron via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Stillfront: Simutronics återtar förläggartjänster10.12.2018 14:11Pressmeddelande

PRESSMEDDELANDE 2018-12-10 Simutronics återtar förläggartjänster för SIEGE: Titan Wars globalt med undantag för Kina Simutronics, en studio inom Stillfront Group, har avslutat ett medförläggaravtal avseende mobilspelet SIEGE: Titan Wars med den New York-baserade förläggarpartnern Tilting Point. Enligt ett nytt avtal kommer Tilting Point fortsatt att tillhandahålla förläggartjänster och marknadsföring av spelet i Kina men på global nivå kommer Simutronics att ansvara för förläggartjänster och marknadsföring av spelet från gruppen. Simutronics är en ledande utvecklare av rollspel och mobila spel som till exempel DragonRealms, GemStone IV och Lara Croft Relic Run, den sistnämnda med mer än 23 miljoner nedladdningar. Tilting Point är den nya generationens spelbolagspartner som förser ledande utvecklingsstudios med expertis, tjänster och operationell support för att optimera högkvalitativa livespel framgångsrikt. "Jag är mycket nöjd över det fortsatta partnerskapet med Tilting Point för den

Stillfront: Simutronics reclaims publishing services10.12.2018 14:11Pressmeddelande

PRESS RELEASE December 10, 2018 Simutronics reclaims the publishing services for SIEGE: Titan Wars globally except China Simutronics Corp, a studio within Stillfront Group AB, has ended a co-publishing agreement regarding the mobile game SIEGE: Titan Wars with New York based publishing partner Tilting Point. According to a new agreement, Tilting Point will continue to provide publishing services and market the game in China but Simutronics will run the publishing services and marketing globally from the Group going forward. Simutronics is a leading developer of online roleplaying and mobile games such as DragonRealms, GemStone IV and Lara Croft Relic Run, the latter with more than 23 million downloads. Tilting Point is a new-generation games partner that provides top development studios with expert resources, services, and operational support to optimize high quality live games for success. "I am very pleased to continue the partnership with Tilting Point for the Chinese market as this

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

Corline Biomedical AB: Patientrekrytering startar i Renaparin-studie30.11.2018 16:37Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att patientrekrytering i den kliniska fas 1-studien RENAPAIR-01 startar. I studien utvärderas bolagets läkemedelskandidat Renaparin® som är under utveckling för att förbättra utfallet av njurtransplantation. Patienter kommer inledningsvis att rekryteras på Akademiska sjukhuset i Uppsala. När de fyra första patienterna utvärderats inleds också rekrytering på Karolinska Universitetssjukhuset i Huddinge. Beskedet att patientrekrytering startar innebär att förberedelsearbetet inför studiestart är avslutat och att till exempel avtal, initieringsmöte, logistik, provhantering och monitorering är hanterat, samt att godkänt prövningsläkemedel nu finns tillgängligt för rekvirering av kirurgerna på transplantationskliniken i Uppsala för dosering till donatornjurar. När första patient doserats kommer detta meddelas separat. Corline har utvecklat och äger rättigheterna till Renaparin® som administreras direkt till den donerade njuren i

Stillfront: Bytro Labs lanserar en ny version av Supremacy 191427.11.2018 08:00Pressmeddelande

PRESSMEDDELANDE 2018-11-27 Bytro Labs, en studio inom Stillfront Group, lanserar en ny version av Supremacy 1914 Spelutvecklaren Bytro Labs, mest kända för sitt framgångsrika strategispel Call of War, har släppt en ny version av sin klassiska speltitel Supremacy 1914. Dagens lansering är den första av tre milstolpar för den nya versionen av Supremacy 1914 - The Great War som släpps 2019. Den första uppdateringen innehåller en komplett omarbetning av området för spelets community, ett nytt utseende för kartan samt ny 3D-teknologi. I nästa steg kommer Bytro Labs att gå vidare till "true cross platform" där spelet tillgängliggörs för fler plattformar, en strategi som tidigare har varit framgångsrik för titeln Call of War. Supremacy 1914 - The Great War släpps för Android senare i år och i början av 2019 släpps spelet för iOS och Steam. Det tredje och sista steget i lanseringen kommer i mitten av 2019 innehållande en större uppdatering avseende både innehåll och funktion, som färdigställer

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum